3D Bioprinting Market – Size, Share, Trends, Growth, Forecast (2024 – 2032)

Introduction:

3D bio printing is a medical application of 3D printers, and this technique involves an array of 3D printing methods to combine cells and biomaterials to produce biomedical parts. During the process of 3D bioprinting, the cell function and viability of the output construct is preserved, which can be used for R&D in various medical areas. 3D bioprinting is mainly engaged for developing organ and tissue constructs, which can be used for R&D of drugs, scaffolds, and development of medical implants.

Global 3D Bioprinting Market Size & Growth:

The global 3D bio printing market was valued at $XX Billion in 2018 and is estimated to reach $XX Billion by 2026, growing at a CAGR of around 26.5% during the forecast period. Factors such as increasing use of 3D bio printing in the drug discovery process, technological advancements for manufacturing customized products, and high demand for organ transplantation are responsible for the market growth during the forecast period. Rise in public and private funding to support 3D bioprinting research activities is also a major factor contributing to the market growth. Despite these drivers, the major restraints hampering the market growth include lack of complete automation, high initial costs, and dearth of trained professionals. Growing awareness related to 3D bio printing and increasing stem cell research, and high usage of 3D printing in cosmetic surgeries are driving the market towards greater opportunities during the forecast period.

Global 3D Bioprinting Market Segments:

The global 3D bioprinting market is segregated based on material, technology, application, end-user, and geography. By material, the market is categorized into hydrogels, extracellular matrices, living cells, and others. The living cells segment is estimated to account the largest market share during the forecast period, due to rising R&D initiatives. The hydrogels segment is projected to register the highest CAGR during the forecast period.

By technology, the magnetic levitation segment is estimated to witness the fastest growth rate during the forecast period, owing to wide application area and increase in adoption of the technique by innovators. Moreover, inkjet 3D bioprinting segment holds the largest market share, due to its low cost and versatility.

By application, the research applications segment holds the largest share in the market. The segment growth is mainly attributed by the factors such as increasing initiatives by market players and university scientists in 3D bioprinting.

By end-user, the pharmaceutical segment shows the significant market growth in the overall market. The pharmaceutical industry is expected to grow multi-fold, thereby increasing the demand for medical pills.

By geography, the market is categorized into North America, South America, Asia Pacific, Europe, and Middle East & Africa. Among all these, North America region is projected to be the dominant regional market during the forecast period. Increasing target population base, presence of well-established companies and sophisticated healthcare infrastructure along with high disposable income levels in the region are expected to propel the market growth. Furthermore, extensive research activities conducted within the region are said to contribute to the market expansion.

Asia Pacific region is projected to grow with the highest CAGR during the forecast period, due to increase in overall and stem cell research activity, high demand for organ transplantation, and growing initiatives by key players.

Global 3D Bioprinting Market Trends:

• In October 2018, the U.S. FDA awarded a grant of $2.5 million to top five research institutions for R&D in bio-manufacturing, including 3D bioprinting.
• China introduced “Made in China 2025” initiative to foster advanced technology in the 3D printing space.
• In February 2018, 3D Systems introduced NextDent 5100, a Figure 4-based 3D bioprinter designed for dental labs. NextDent 5100 facilitates high-speed 3D bioprinting to produce dental appliances and sacrificial castings.
• In January 2019, The Institute for Technology Inspired Regenerative Medicine in Netherlands collaborated with Aspect Biosystems, a Canadian company, for the advancements in 3D printing and regenerative medicine.

Global 3D Bioprinting Market Research Report Include:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
• Expertise investment opportunities by analyst to the individual and organization to have better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
• Organovo Holdings, Inc.
• Cellink AB.
• Bio3D Technologies.
• Aspect Bio Systems Ltd.
• Stratasys Ltd.
• Materialise NV.

Along with these companies, there were many other companies considered/ cited in the report while analyzing the 3D bioprinting market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. other players have considerable presence owing to its robust brand image, geographical reach, and strong customer base.